These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 24557997)

  • 1. [Dosing irregularities and hypoglycaemia in insulin treatment of type 2 diabetes: the GAPP2TM study].
    Grundner M
    Dtsch Med Wochenschr; 2014 Feb; 139(9):430-3. PubMed ID: 24557997
    [No Abstract]   [Full Text] [Related]  

  • 2. Dosing irregularities and self-treated hypoglycemia in type 2 diabetes: results from the Canadian cohort of an international survey of patients and healthcare professionals.
    Leiter LA; Boras D; Woo VC
    Can J Diabetes; 2014 Feb; 38(1):38-44. PubMed ID: 24485212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming barriers to insulin replacement.
    Kuritzky L
    J Fam Pract; 2009 Aug; 58(8 Suppl):S25-31. PubMed ID: 19679028
    [No Abstract]   [Full Text] [Related]  

  • 4. [Incidence of severe hypoglycemia in relation to metabolic control and patient knowledge].
    Ratzmann KP; Schimke E
    Med Klin (Munich); 1995 Oct; 90(10):557-61. PubMed ID: 7500918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced hypoglycaemia and the detection of myocardial injury using an ultrasensitive troponin assay.
    Quah J; Carlton E; Rana O; Byrne CD; Senior R; Anstey C; Greaves K
    Int J Cardiol; 2016 Jul; 215():446-8. PubMed ID: 27131269
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypoglycaemia causes both daytime and nighttime QTc interval prolongation in patients with type 2 diabetes receiving insulin treatment.
    Makrilakis K; Stathi C; Vlahodimitris I; Kalopita S; Thomakos P; Konstantopoulos P; Perrea D; Katsilambros N; Liatis S
    Diabetes Metab; 2018 Mar; 44(2):175-177. PubMed ID: 29029946
    [No Abstract]   [Full Text] [Related]  

  • 7. Psychological insulin resistance in type 2 diabetes patients regarding oral antidiabetes treatment, subcutaneous insulin injections, or inhaled insulin.
    Petrak F; Herpertz S; Stridde E; Pfützner A
    Diabetes Technol Ther; 2013 Aug; 15(8):703-11. PubMed ID: 23844571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoglycemia, treatment discontinuation, and costs in patients with type 2 diabetes mellitus on oral antidiabetic drugs.
    Bron M; Marynchenko M; Yang H; Yu AP; Wu EQ
    Postgrad Med; 2012 Jan; 124(1):124-32. PubMed ID: 22314122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observational, open-label study of type 1 and type 2 diabetes patients switching from human insulin to insulin analogue basal-bolus regimens: insights from the PREDICTIVE study.
    Hermansen K; Dornhorst A; Sreenan S
    Curr Med Res Opin; 2009 Nov; 25(11):2601-8. PubMed ID: 19739940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycaemic control in type 2 diabetes mellitus patients undergoing major surgery: comparison of three subcutaneous insulin regimens.
    Mathur SK; Bansal A; Khan ZY
    J Indian Med Assoc; 2009 Nov; 107(11):759-61. PubMed ID: 20469779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for better insulin therapy.
    Grunberger G
    Diabetes Obes Metab; 2013 Mar; 15 Suppl 1():1-5. PubMed ID: 23448196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premixed insulin treatment for type 2 diabetes: analogue or human?
    Garber AJ; Ligthelm R; Christiansen JS; Liebl A
    Diabetes Obes Metab; 2007 Sep; 9(5):630-9. PubMed ID: 17697056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal insulins: Pharmacological properties and patient perspectives.
    Abrahamson MJ
    Prim Care Diabetes; 2010 Apr; 4 Suppl 1():S19-23. PubMed ID: 20394887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starting or switching to biphasic insulin aspart 30 (BIAsp 30) in type 2 diabetes: a multicenter, observational, primary care study conducted in Finland.
    Mäkelä JK; Schmüser C; Askonen K; Saukkonen T
    Diabetes Res Clin Pract; 2012 Jan; 95(1):10-8. PubMed ID: 22078072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of severe hypoglycaemia in type 1 and type 2 diabetes during conventional insulin therapy.
    Gürlek A; Erbaş T; Gedik O
    Exp Clin Endocrinol Diabetes; 1999; 107(3):220-4. PubMed ID: 10376450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluating the feature of hypoglycemia detected by continuous glucose monitoring system during temporary continuous subcutaneous insulin infusion in type 2 diabetes patients].
    Li M; Zhou J; Bo YQ; Lu W; Jia WP; Xiang KS
    Zhonghua Yi Xue Za Zhi; 2008 Jun; 88(24):1679-82. PubMed ID: 19024537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medically minimising the impact of hypoglycaemia in type 2 diabetes: a review.
    Noh RM; Graveling AJ; Frier BM
    Expert Opin Pharmacother; 2011 Oct; 12(14):2161-75. PubMed ID: 21668402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of nocturnal hypoglycaemia with bedtime glucose level during continuous subcutaneous insulin infusion in type 2 diabetics].
    Li M; Zhou J; Bao YQ; Lu W; Jia WP
    Zhonghua Yi Xue Za Zhi; 2010 Nov; 90(42):2962-6. PubMed ID: 21211306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.